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Objectives: Knowledge of disease management and treatment skills are necessary,
but not sufﬁcient, to improve adherence. This study examined:
1. gaps in knowledge of disease management,
2. deﬁcits in treatment skills,
3. impact of age and gender, and
4. convergence between teen and parent knowledge.
Methods: Knowledge of Disease Management (KDM-CF) in four domains, General
Health, Lung Health, Nutrition, and Treatments, and the Skills Checklist (scored as
percent correct) were administered to 571 teens (M = 14.6 years, SD = 2.6; 307 girls)
and 249 parents in iCARE at 18 CF centers in the US.
Results: Signiﬁcant gaps in knowledge were observed, with lowest scores on the
Nutrition Scale (M = 68.9 [15.4]). Skills were best for enzymes (M = 94.5 [12.00])
and worst for MDIs (M = 68.8 [18.8]) and acapella (M = 69.9 [23.1]). Age was
positively correlated with Knowledge Scores (r = 0.46, p< 0.001) but not Skills.
Older teens had higher KDM-CF Total Scores (M = 82.4 [9.5]) than younger teens
(M = 71.8 [13.4], p< 0.001). Knowledge scores did not differ by gender, but girls
(M = 82.8 [17.7]) had signiﬁcantly higher Nebulizer Skills than boys (M = 79.4
[19.2], p< 0.05). Parents had higher KDM-CF Total Scores (M = 84.7 [7.5]) than
adolescents (M = 75.1 [14.2]), and paired t-tests revealed signiﬁcant differences in
KDM scores by dyads (p< 0.001).
Conclusions: Remediating gaps in knowledge of disease management and skill
deﬁcits are critical targets for intervention and should be assessed annually. These
measures provide individual teen and parent data to focus teaching and retraining.
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Objectives: The purpose of this study is to evaluate the psychometric properties of
health belief measures developed for a CF medication regimen. We hypothesized
that Self-Efﬁcacy (SE), Motivation to Adhere (MA), Importance of Adhering (IA),
and Beneﬁts of Taking Medicine (BTM), would be positively associated with
adherence while Beneﬁts of NOT Taking Medicine (BNTM) would be negatively
associated.
Methods: 86 older teens and adults with CF [Age M=30 yrs (SD= 11); 51% male;
94% white; FEV1pp M=68.5% (SD= 21.8%)] completed the measures (Table).
Pharmacy reﬁll data was obtained and a medication possession ratio (MPR)
was calculated for each prescribed pulmonary medication (azithromycin, dornase
alpha, hypertonic saline, and inhaled aztreonam lysine, colistin, & tobramycin) and
averaged to create an overall MPR.
Results: Overall median MPR was 0.60 (IQR: 0.39–0.79) and 24% of participants
had an MPR 0.80. All measures had good reliability and were correlated as
hypothesized with MPR (Table) except for the BTM and BNTM scales. Having
an MPR 0.80 was associated with higher SE, MA, IA, and BTM scores but not
the BNTM score.
Conclusions: The data supports the reliability and validity of the SE, MA and
IA scales. The BTM and BNTM measures were not associated with adherence
suggesting that there may be unique pros and cons ascribed to each drug that
cannot be captured by a summary measure.
Reliability & Validity of CF-Speciﬁc Measures
Measure Cronbach
alpha
Spearman Rho
Correlation with
Overall MPR
M(SD)
if MPR< 0.80
(n = 65)
M(SD)
if MPR 0.80
(n = 21)
Self-Efﬁcacy (SE; 19 items) 0.88 0.43** 132.5 (39.2) 165.5 (34.9)**
Motivation to Adhere (MA; 3 items) 0.83 0.39** 20.8 (7.2) 26.8 (4.79)**
Importance of Adhering (IA; 3 items) 0.84 0.31* 23.7 (5.97) 28.1 (3.76)*
Beneﬁts of Taking Medicine (BTM; 19 items) 0.88 0.16 52.2 (10.9) 58.2 (10.9)*
Beneﬁts of NOT Taking Medicine (BNTM;
16 items)
0.83 −0.20 30.9 (9.41) 26.2 (10.2)
